Summit Therapeutics (SMMT) News Today $20.90 -0.38 (-1.79%) As of 10:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMMT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period HC Wainwright Reiterates Buy Rating for Summit Therapeutics (NASDAQ:SMMT)3 hours ago | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at UBS Group3 hours ago | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Rating Increased to Hold at Wall Street ZenJune 30 at 2:51 AM | americanbankingnews.comSummit Therapeutics PLC (NASDAQ:SMMT) Stock Position Lifted by Sovran Advisors LLCJune 29 at 6:41 AM | marketbeat.comLisanti Capital Growth LLC Takes Position in Summit Therapeutics PLC (NASDAQ:SMMT)June 29 at 6:33 AM | marketbeat.comWall Street Zen Upgrades Summit Therapeutics (NASDAQ:SMMT) to "Hold"June 29 at 3:22 AM | marketbeat.comSummit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 29 at 3:21 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 27, 2025 | prnewswire.comSummit Therapeutics Breaks Above 200-Day Moving Average - Bullish for SMMT - NasdaqJune 26, 2025 | nasdaq.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 23, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 22, 2025 | prnewswire.comWorld Equity Group Inc. Sells 14,062 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)June 22, 2025 | marketbeat.comGAMMA Investing LLC Purchases 15,331 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)June 21, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Downgraded to "Sell" Rating by Wall Street ZenJune 21, 2025 | marketbeat.comSummit Therapeutics PLC (NASDAQ:SMMT) Shares Sold by Five Pine Wealth ManagementJune 20, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 18, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 17, 2025 | prnewswire.comAnalysts Offer Predictions for SMMT Q2 EarningsJune 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 15, 2025 | globenewswire.comPolianta Ltd Takes $1.17 Million Position in Summit Therapeutics Inc. (NASDAQ:SMMT)June 13, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading Up 5.1% - Time to Buy?June 12, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 12, 2025 | prnewswire.comSummit Therapeutics (NASDAQ:SMMT) Rating Increased to Strong Sell at Leerink PartnrsJune 12, 2025 | marketbeat.comLeerink Partners Initiates Coverage of Summit Therapeutics (SMMT) with Underperform RecommendationJune 11, 2025 | msn.comMerck rival Summit draws a rare sell-equivalent ratingJune 11, 2025 | msn.comWhy Summit Therapeutics Stock Tanked TodayJune 11, 2025 | fool.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down - Here's WhyJune 11, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Earns Underperform Rating from Analysts at Leerink PartnersJune 11, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Here's What HappenedJune 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 10, 2025 | globenewswire.comEquities Analysts Set Expectations for SMMT FY2026 EarningsJune 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 7, 2025 | prnewswire.comSummit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 6, 2025 | globenewswire.comSummit Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare ConferenceJune 5, 2025 | finance.yahoo.comWhy Summit Therapeutics Inc. (SMMT) Crashed On WednesdayJune 5, 2025 | msn.comAmeriprise Financial Inc. Acquires New Stake in Summit Therapeutics Inc. (NASDAQ:SMMT)June 5, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 3.6% - Here's What HappenedJune 4, 2025 | marketbeat.comWhy Summit Therapeutics Inc. (SMMT) Skyrocketed On TuesdayJune 4, 2025 | msn.comSummit Therapeutics Inc. (NASDAQ:SMMT) Receives Average Rating of "Buy" from AnalystsJune 4, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Sees Large Volume Increase - Should You Buy?June 3, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Here's WhyJune 3, 2025 | marketbeat.comSummit Therapeutics: Market Overreaction Creates OpportunityJune 2, 2025 | seekingalpha.comSummit Therapeutics (NASDAQ:SMMT) Earns "Market Outperform" Rating from JMP SecuritiesJune 2, 2025 | marketbeat.comIs Beaten-Down Summit Therapeutics Stock a Bad-News Buy?June 2, 2025 | fool.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by Nuveen Asset Management LLCJune 1, 2025 | marketbeat.comSummit Therapeutics Target of Unusually Large Options Trading (NASDAQ:SMMT)May 31, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down - Should You Sell?May 31, 2025 | marketbeat.comWhy Summit Therapeutics Inc. (SMMT) Crashed On FridayMay 31, 2025 | msn.comJefferies Financial Group Inc. Purchases Shares of 45,001 Summit Therapeutics Inc. (NASDAQ:SMMT)May 31, 2025 | marketbeat.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.820.90▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼87▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Merck & Co., Inc. News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today BioNTech News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Qiagen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMMT Stock Alerts